Gilead Sciences GILD Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gilead Sciences's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gilead Sciences's common stock, shares authorized (in shares)?
- Gilead Sciences (GILD) reported common stock, shares authorized (in shares) of 5.6B in Q1 2026.
- How has Gilead Sciences's common stock, shares authorized (in shares) changed year-over-year?
- Gilead Sciences's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from 5.6B to 5.6B.
- What is the long-term trend for Gilead Sciences's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Gilead Sciences's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 5.6B to 5.6B.